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Abstract
Given the increasing prevalence of HIV, it is important to identify factors associated with safer sex behaviors
between people living with HIV and their partners. Utilizing a diverse sample of 242 HIV-infected adults
[n = 69 men who have sex with men (MSM); n = 68 men who have sex with women (MSW); n = 105 women
who have sex with men (WSM)], we examined the association between serostatus disclosure and unprotected
anal or vaginal intercourse (UAVI) and the moderating effect of sexual behavior group on this association.
Overall, 88.7% disclosed to their current partner. Approximately 18.8% of MSM, 17.7% of MSW, and 29.5% of
WSM reported UAVI. Controlling for age, time since diagnosis, and partner serostatus, we found main effects
on UAVI for disclosure and sexual behavior group; specifically, disclosure was inversely related to unprotected
sex [AOR = 0.09, 95% CI (0.02, 0.43), p < 0.001], and MSM were less likely to engage in UAVI relative to
WSM [AOR = 0.11, 95% CI (0.17, 0.82), p < 0.05]. However, the relationship between disclosure and UAVI
was not moderated by sexual behavior group. Future strategies that aim to increase disclosure to partners may
consider focusing on its value as a means by which to reduce sexual risk behavior.
Introduction
One aspect of promoting and maintaining sexualhealth is the avoidance of transmitting or acquiring a
sexually transmitted infection through engagement in safer
sex behaviors. However, practicing safer sex presents chal-
lenges that may be greater for individuals with chronic sex-
ually transmitted infections, including people living with
HIV (PLHIV). Although being diagnosed with HIV has been
associated with a significant reduction in sexual risk behav-
ior,1–3 a substantial minority of PLHIV continue to engage in
unprotected sex.4–7 Others may decrease sexual risk behavior
immediately after diagnosis but show a rebound in these
behaviors in subsequent months or years. For example, one
study of men who have sex with men (MSM) who were
recently infected with HIV found that the percentage of un-
protected sex with unknown serostatus partners decreased
from 49% at baseline to 25% at 6 months, but then rebounded
to 71% at 12 months.2 Another study that followed trends in
sexual behavior pre- and post-HIV diagnosis found a 53%
probability of unprotected sex at 1 year after diagnosis, but an
increase to 61% 4 years after diagnosis.5 Ongoing efforts to
identify those factors that promote safer sexual behaviors
between PLHIV and their partners are needed.
Serostatus disclosure is fundamental to our understanding of
the experience of HIV as an illness, because of its connection to
privacy, ethical responsibility, and its possible function in pre-
vention of disease transmission risk. Several reasons underlie
serostatus disclosure as one possible component of risk reduc-
tion. Serostatus disclosure provides an opportunity for sexual
partners to make informed decisions about a tolerable level of
transmission risk,8 leading them to either decide to forego
sexual activity or to engage in deliberately safer sexual behav-
iors. From a public health perspective, disclosing to a sexual
partner may prompt those who are unaware of their HIV status
to seek testing.9 Furthermore, the success of recent clinical trials
of antiretroviral preexposure prophylaxis (PrEP)10–12 highlights
how disclosure may allow uninfected individuals to make de-
cisions about the use of PrEP to reduce further their risk of HIV
acquisition. As PrEP and other options have become available,
the possible benefits of serostatus disclosure are increasingly
recognized, including among subgroups such as pregnant
women.13 Despite the possible benefits, it is clear that decisions
to disclose are complex and often influenced by many factors.
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While some PLHIV are motivated to disclose because it offers
opportunities for social support,10–11 makes serosorting and
PrEP discussions possible, and can make seeking and remaining
in medical care easier,16 disincentives to revealing one’s status
are common, including fears of stigmatization,12,13 rejection,14
or physical and emotional abuse.15
In the past 15 years, the pace of theory development spe-
cific to HIV serostatus disclosure has grown but with a lim-
ited scope; a general focus on disclosure likelihood rather
than disclosure outcomes has impeded understanding the
relationship between serostatus disclosure decisions and
sexual behavior choices for PLHIV. Most theories, such as
disease progression theory, emphasize the processes and
motivations of the behavior based on beliefs about the costs
and benefits associated with disclosure.16–18 Accordingly,
disclosure decisions are postulated to occur most often when
HIV has advanced to symptomatic AIDS, making it chal-
lenging to hide one’s illness.19,20 However, empirical research
has not demonstrated consistent associations between disease
stage and disclosure to sexual partners.22 Alternatively, con-
sequence theory proposes that the decision to disclose one’s
HIV serostatus occurs after a conscientious analysis of the
anticipated positive and negative outcomes of that decision.23
Empirical studies of consequence theory have shown to predict
disclosure to friends and family members, but not to sexual
partners.22,26 Finally, the disclosure processes model improves
upon previous theories by recognizing the role played by the
antecedent goals of disclosure, the mediating processes of
disclosure decisions, and the outcomes of these decisions. This
model specifies that disclosure can affect dyadic outcomes
because knowledge of a partner’s serostatus can influence
sexual risk perceptions and consequently sexual risk behav-
ior.27 While the disclosure processes model recognizes that
serostatus disclosure affects sexual risk behavior, it does not go
so far as to postulate the direction of the effect, perhaps be-
cause the effect may vary in different contexts or in different
groups.
The primary gaps in these theories are a general lack of dis-
tinction between the target of the disclosure information (e.g.,
family, sexual partners) and the absence of their application
among different groups of PLHIV, particularly men and women
with opposite sex partners.23–27 We know there are differences
in sexual risk behavior patterns between HIV-infected MSM,
men who have sex with women (MSW), and women who have
sex with men (WSM).28–33 These differences suggest that the
costs, benefits, and outcomes associated with serostatus disclo-
sure may also differ between groups.22 In fact, several studies
have found differences between these three groups in serostatus
disclosure to sex partners.18,32,34,35 Specifically, HIV-positive
MSM are typically less likely to disclose to sexual partners
relative to MSW and WSM, citing fears of rejection, issues of
confidentiality, and concerns of stigmatization as barriers to HIV
disclosure.19,36 These findings, combined with the disclosure
processes model, suggest that disclosure goals and effects on
behavior may vary for different sexual behavior groups. Addi-
tional empirical attention may help us more fully understand
the role of disclosure, not merely the likelihood that disclosure
will occur, in facilitating safer sex as a behavioral outcome.
Unlike studies of sexual communication among the gen-
eral population, empirical studies examining the relationship
between serostatus disclosure and condom use among
PLHIV are few and their findings are mixed. Some studies
have found a positive association between serostatus dis-
closure and condom use.37–40 Using data from a heteroge-
neous study of heterosexual, gay, and bisexual PLHIV, a
recent mathematical modeling analysis concluded that dis-
closure can reduce the risk of HIV transmission by between
17.9% to 40.6% by increasing condom use rates among
prospective partners who agree to engage in sexual activity.41
Other studies, however, found no association between dis-
closure and condom use.42–44 Although the body of literature
attempting to understand the relationship between serostatus
disclosure and unprotected sex among PLHIV is growing, it
has been common for studies to focus exclusively on specific
behavioral risk groups, such as MSM or bisexual men, or to
make direct comparisons between genders by combining
MSM and MSW and comparing them collectively to women.
Study designs that combine sexual behavior groups may miss
important between-group differences that can aid in devel-
opment of effective interventions targeting unique behaviors
within and among these three groups.28,30,31 Inconsistencies
in previous research and the relatively few studies directly
comparing sexual behavior groups suggest that critical gaps
exist in our understanding of the relationship between ser-
ostatus disclosure and unprotected sexual activity among
PLHIV.
The goal of the current research was to explore the central
hypotheses that HIV serostatus disclosure was inversely as-
sociated with unprotected sex and that membership in a
certain sexual behavior group (MSM, MSW, and WSM)
moderates this association. Using the disclosure processes
model as a guiding theoretical framework, we set out to an-
swer explored three specific research questions: (1) Do HIV
serostatus disclosure and unprotected sex vary between sex-
ual behavior groups? (2) Is serostatus disclosure inversely
associated with unprotected sex? (3) Does the strength of the
relationship between serostatus disclosure and unprotected
sex vary by sexual behavior group? The answers to these
questions will help determine whether and the extent to
which serostatus disclosure and sexual behavior group




The data for the current study come from the baseline
assessment of SafeTalk, a randomized, controlled trial that
evaluated the efficacy of a motivational interviewing-based,
safer sex intervention for 490 HIV-infected patients in clin-
ical care.45 Data were collected through an audio computer-
assisted self-interview (ACASI) that lasted approximately
30–60 min. For the present study, our analysis was restricted
to SafeTalk participants who reported being sexually active
with only one partner in the previous 3 months to allow for
linkage of reported sexual behavior with disclosure to a
specific sexual partner (n = 242). The University of North
Carolina at Chapel Hill’s Office for the Protection of Human
Research approved all study procedures.
Measures
Demographic, clinical, and substance use factors. We
assessed participants’ gender, age, race, education, and
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employment status as well as self-reported clinical charac-
teristics related to HIV (current antiretroviral therapy, whe-
ther their most recent viral load test was undetectable, date of
diagnosis). We also assessed amount of alcohol, marijuana,
and crack cocaine use in the last 3 months and dichotomized
each substance use variable (any use/no use).
Sexual behavior groups. We determined participants’
sexual behavior group membership based on their gender and
the gender of their reported sexual partner to create three
groups: MSM, MSW, and WSM. Of note, four women re-
ported sexual behavior exclusively with other women; these
women were not included in the current project given the
small sub-sample size.
Partner serostatus. Participants were asked about the
HIV serostatus of their sexual partner with response options
of ‘‘positive,’’ ‘‘negative,’’ or ‘‘not sure.’’ We dichotomized
this variable into seroconcordant (i.e., partner’s HIV ser-
ostatus positive) versus serodiscordant (i.e., partner’s HIV
serostatus negative or unknown) partnerships to reflect part-
ners at risk of HIV acquisition.
HIV disclosure. We assessed HIV serostatus disclosure as
an active, voluntary behavior using a one-item question that
asked participants, ‘‘Did this partner know that you were HIV-
positive because you told him/her that you were positive?’’
Sexual behaviors. Based on the study participant’s gen-
der and the reported partner’s gender, the ACASI gathered
detailed information about sexual behavior in the last 3
months. Participants were asked the number of times they had
vaginal or anal intercourse with their partner. For each type of
sex act, participants were also asked how many times a
condom was used from the beginning to the end of penetra-
tion. For the current study, we used this sexual behavior data
to create outcome variables representing whether the indi-
vidual had engaged in any unprotected sex acts in the last 3
months. The outcome variables were combined and then di-
chotomized, since they were not normally distributed, into
0 = no unprotected anal or vaginal intercourse (UAVI) and
1 = at least one episode of UAVI.
Statistical analyses
To answer our research questions, we analyzed our data in
three stages. First, we conducted descriptive analyses of
baseline characteristics of the three groups (MSM, MSW,
and WSM) to characterize the study sample. Second, to de-
termine if the prevalence of serostatus disclosure and UAVI
varied between the sexual behavior groups, we planned a
two-step testing approach. A two degrees of freedom Chi-
square statistic was calculated to test the global hypothesis of
equality of prevalence among the three groups. If this test
rejected the global null hypothesis, we then conducted pair-
wise comparisons with one degree of freedom Chi-square
statistics with Bonferroni-adjusted post-hoc tests to maintain
a family-wise Type 1 error rate of p < 0.05. Finally, to test the
joint effects of serostatus disclosure status and sexual be-
havior group on UAVI, we constructed a multivariate logistic
regression model with disclosure status, sexual behavior
group, and their interactions as predictors. The model also
included a set of potential confounding variables (age, time
since HIV diagnosis, and partner HIV serostatus) selected
based on their associations with both HIV serostatus disclo-
sure and unprotected sex in previous studies.26,37,43,46,47 We
followed the strategy of testing the global hypothesis of no
interaction first. If interactions were present, the plan was to
use the predicted probabilities to examine the disclosure
effect by sexual behavior groups. We report adjusted odds
ratios (AORs) and 95% confidence intervals (CIs). We used
STATA version 12 (College Station, Texas) for all data
analyses.
Results
Serostatus disclosure, sociodemographic, and health
characteristics of study participants
Participants in the current study included 242 individuals:
69 MSM (28.5%), 68 MSW (28.1%), and 105 WSM (43.4%).
Participants ranged in age from 19–67 (M = 42.7, SD = 8.9).
Most participants were African American (71.1%), and ap-
proximately two-thirds of the sample were unemployed. More
than half reported an undetectable viral load and the average
length of time since HIV diagnosis was 9.5 years (range = 6
months to 23.25 years, SD = 5.7). With respect to partner ser-
ostatus, nearly 65% of the sample had sexual partners who
were either HIV-negative or of unknown serostatus (i.e., ser-
odiscordant). Analyses of variance and Chi-square tests de-
tected significant differences between sexual behavior groups
on age, race, educational attainment, and alcohol use. In the
full sample, 88.7% of individuals disclosed their serostatus to
their current sexual partner. Disclosure was nonsignificantly
less likely for MSM (81.2%) relative to MSW (92.5%) and
WSM (91.2%) [v2 (2) = 5.50, p = 0.06]. Additional participant
demographic, clinical, substance use, and partnership charac-
teristics are shown in Table 1.
Relationship between HIV serostatus disclosure
with UAVI
Table 2 presents the prevalence of UAVI in the full sample
and stratified among those individuals with and without HIV
serostatus disclosure to their partners. Regarding unprotected
sexual behavior in the past 3 months, 23.1% of participants
reported engaging in UAVI. Within sexual behavior groups,
18.8% of MSM, 17.7% of MSW, and 29.5% of WSM re-
ported engaging in UAVI. However, these proportions did
not differ significantly [v2 (2) = 4.28, p = 0.11]. The preva-
lence of UAVI among those who disclosed was 16.1% for
MSM, 17.7% for MSW, and 26.9% for WSM. The observed
UAVI prevalence among those non-disclosing showed con-
siderable variations (Table 2). A global test of the interaction
between disclosure status and sexual behavior groups in
predicting UAVI did not reject the null hypothesis of no
interaction, indicating that disclosure status effects do not
vary by sexual behavior groups [v2 (2) = 3.11, p = 0.21].
Multivariate logistic regression. Table 3 describes the
factors associated with UAVI. Serostatus disclosure emerged
as a significant correlate of UAVI in the full sample
[AOR = 0.09, 95% CI (0.02, 0.43), p < 0.001], such that par-
ticipants who disclosed their HIV status had significantly
lower odds of engaging in UAVI than those who withheld
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disclosure. Relative to women, MSM and MSW had lower
odds of engaging in UAVI [AOR = 0.11, 95% CI (0.17, 0.82),
p < 0.05 and AOR = 0.09, 95% CI (0.01, 1.45), p = 0.09, re-
spectively]. In the adjusted analysis with confounding vari-
ables included, a global test of interaction between serostatus
disclosure and sexual behavior group on unprotected sex
showed no statistical significance ([v2 (2) = 1.74, p = 0.42]).
Discussion
While it is well established that openly communicating
about sexual health issues with a partner can promote safer
sexual decision-making, the relationship between sexual
communication and safer sex practices may be more complex
for PLHIV.48 For all couples, sexual health communication
may involve discussion of previous sexual partners or history
of sexually transmitted infections. For those who are infected
with HIV, however, these conversations present substantial
risk because they involve disclosure of a stigmatizing con-
dition. For some HIV-infected individuals, practicing safer
sex may actually provide a means to avert the need to com-
municate one’s serostatus and avoid communicating about
sexual health issues altogether. We sought to assess whether,
among a diverse group of PLHIV, there was an association
between serostatus disclosure and unprotected sex. MSM,
MSW, and WSM did not differ in their reported serostatus
disclosure. We found that participants who disclosed their
HIV status were significantly less likely to engage in un-
protected sex than those who did not disclose. We also found
that, relative to women, MSM and MSW were less likely to
report unprotected sex.
The disclosure processes model recognizes that for PLHIV
communication affects dyadic outcomes like sexual behav-
ior, but the exact direction and strength of this effect can
Table 1. Descriptive Characteristics of Study Sample
Full sample MSM MSW WSM
N = 242 N = 69 N = 68 N = 105
n (%) n (%) n (%) n (%) ANOVA or v2
Serostatus disclosure 211 (88.7) 56 (81.2) 62 (92.5) 93 (91.2) v2 (2) = 5.50
Demographic characteristics
Age [M (SD)] 42.7 (8.9) 39.9 (9.6)a 44.5 (8.5)b 43.3 (8.2)b F (2,239) = 5.47**
Race
African American/black 172 (71.1) 40 (58.0)a 53 (77.9)b 79 (75.2) v2 (2) = 8.21*
Caucasian/white 47 (19.4) 21 (30.4) 8 (11.8) 18 (17.2)
Other 23 (9.5) 8 (11.6) 7 (10.3) 8 (7.6)
Education
High school or less 140 (57.9) 18 (26.1)a 52 (76.5)b 70 (66.7)b v2 (2) = 41.57***
Some college or more 102 (42.1) 51 (73.9) 16 (23.5) 35 (33.3)
Employment
Not employed 151 (62.4) 36 (52.2) 46 (67.6) 69(65.7) v2 (2) = 4.53
Full or part-time 91 (37.6) 33 (47.8) 22 (32.4) 36 (34.3)
Clinical characteristics
Currently on ART 205 (84.7) 63 (91.3) 62 (91.2) 80 (76.2) v2 (2) = 5.96
Undetectable viral load 133 (54.9) 40 (57.9) 38 (55.1) 55 (52.4) v2 (2) = 0.53
Years since diagnosis [M (SD)] 9.5 (5.7) 8.3 (5.7) 10.4 (5.8) 9.6 (5.6) F (2,235) = 2.32
Substance use characteristics
Alcohol use 128 (53.1) 47 (68.1)a 42 (61.8)a 39 (37.5)b v2 (2) = 13.51**
Marijuana use 42 (17.9) 10 (14.5) 17 (25.8) 15 (14.3) v2 (2) = 3.89
Crack use 32 (13.6) 5 (7.3) 10 (15.2) 17 (16.2) v2 (2) = 3.49
Partner serostatus
HIV-positive 85 (35.1) 25 (36.2) 29 (42.7) 31 (29.5) v2 (2) = 3.17
HIV-negative 119 (49.2) 29 (42.0) 32 (47.1) 58 (55.2) v2 (2) = 3.07
Unknown 38 (15.7) 15 (21.7) 7 (10.3) 16 (15.2) v2 (2) = 3.42
MSM, men who have sex with men. ANOVAs were used to test group differences on continuous variables; v2 tests were used to test
group differences in dichotomous variables. Different superscripts within a row (a,b) indicate significant differences ( p < 0.05) between
groups with Bonferroni-adjusted post-hoc tests. *p < 0.05, **p < 0.01, ***p < 0.001.
Table 2. Percent Engaging in UAVI by Serostatus Disclosure and Sexual Behavior Group
MSM Heterosexual men Heterosexual women Full sample
Sexual behavioral group/disclosure group N = 69 N = 67 N = 102 N = 238
Disclosure 16.1 17.7 26.9 21.3
Nondisclosure 30.8 20.0 66.7 40.7
Combined disclosure/nondisclosure group 18.8 17.7 29.5 23.1
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depend on an individual’s goals in communicating one’s
serostatus.27 Since theoretical and empirical work suggests
that members of different sexual behavior groups may differ
in their goals regarding sexual communication, we sought to
assess whether the protective effect of serostatus disclosure
applied equally to all individuals or if it was specific to cer-
tain sexual behavior groups. Results of the current study
provide evidence that the protective effects of serostatus
disclosure may indeed apply equally: there were not signifi-
cant differences in the relationship between disclosure and
sexual risk behavior among the three groups we examined.
Our study showed evidence of an inverse association be-
tween disclosure and unprotected sex, consistent with pre-
vious research in this population37–40 and consistent with the
disclosure processes model that suggests disclosure influ-
ences perceptions of risk. Some HIV-infected adults may
consider disclosing their serostatus to be a means of trans-
ferring responsibility for HIV prevention efforts (e.g., con-
dom use) to their partners. Partners who perceive HIV
acquisition as less threatening may be more accepting of
various risky sexual practices, including unprotected sex,
while other partners may elect to practice safer sex.
Given the high prevalence of disclosure in our sample, it is
also possible that participants used strategies that took into
account partner serostatus and engaged in negotiation with
their partners about the selection of other risk reduction
strategies beyond condom use.49 For example, participants
may have adopted serosorting (i.e., choosing to have sex with
a seroconcordant partner) or used seropositioning (i.e., taking
on the receptive position during unprotected anal sex) as a
protective behavior to reduce the risk of transmitting HIV.
Since the use of seroadaptive strategies is dependent on
serostatus disclosure,45,47 future interventions that involve
negotiation of both serostatus disclosure and safer sex are
warranted, particularly for those individuals with ser-
odiscordant partners at risk of acquiring HIV.51
Nearly 60% of participants who withheld disclosure re-
ported no instances of unprotected sex in the previous 3
months. Several possible explanations exist for this finding.
First, some PLHIV may follow a disclosure/sexual behavior
pattern of ‘‘uninformed protection,’’ believing that consistent
condom use obviates the need for a discussion of each other’s
serostatus.46 These individuals may engage in protected
sexual activity stemming from the HIV-infected individual’s
sense of personal responsibility to protect others, yet with-
hold disclosure to protect themselves from possible negative
partner reactions. While the intent may be to practice safer
sex on a consistent basis, this behavior may not always occur,
particularly since the lifelong commitment to condom use
may be challenged by ‘‘safe sex fatigue’’ over time.6 Fur-
thermore, HIV serostatus disclosure to sexual partners does
not guarantee engagement in protective behaviors to avoid
transmission. In our sample, more than 20% of participants
followed this disclosure/sexual behavior pattern termed
‘‘informed exposure.’’46 For some PLHIV and their partners,
the shared decision-making for engagement in unprotected
sexual activity does not hinge on disclosure. Finally, select-
ing partners who are known or assumed to be of the same HIV
status in order to engage in unprotected sex (i.e., serosorting)
may explain the ‘‘informed exposure’’ behavioral pattern
observed in 20% of our sample.
Our findings suggest it could be beneficial for public health
campaigns to encourage the general public to engage in more
open sexual communication when entering new sexual rela-
tionships with discussions that emphasize not only condom
use, but also asking partners about any history of sexually
transmitted infections, including HIV. This ‘‘normalizing’’
of serostatus discussion could remove the burden completely
from people living with HIV and hence reduce the barriers to
sexual communication, including disclosure. Given the dis-
proportionate expectation for and obligation of disclosure
assigned to PLHIV rather than uninfected persons,19 future
research and practice directions may consider the need for an
improved understanding of mutual serostatus disclosure be-
tween partners regardless of HIV serostatus. By positioning
the responsibility of serostatus disclosure exclusively on
PLHIV, the risks of marginalization and stigmatization of
this population, with their many negative consequences, is
likely to continue.52 Furthermore, as PrEP begins to play a
more pivotal role in an integrated HIV prevention strategy, its
effectiveness relies on its acceptability, adoption, and sus-
tainability particularly among high-risk individuals.53–55 Its
success also hinges on mutual serostatus disclosure between
sexually active partners so that HIV-negative partners are
informed of the seropositivity of a partner and aware of their
own HIV serostatus before they can make a decision to ini-
tiate PrEP.
Both practice and research implications of our findings are
useful for developing future risk reduction interventions for
PLHIV and their partners. Additional research, particularly
more qualitative work, might help to identify motivations for
having unprotected sex, as well as an understanding of the
role that poor sexual communication or various risk percep-
tions may play, particularly in the absence of serostatus dis-
closure, for both HIV-infected individuals and their partners.
Finally, intervention efforts for PLHIV should continue to
include education about transmission risk behaviors, dis-
cussion of perceived risk for acquiring sexually transmitted
infections, and effective risk reduction strategies for both
partners regarding transmission of drug-resistant strains or
other sexually transmitted infections.
Limitations
While our results highlight key points relevant to future
interventions, it is important to consider our findings in light
Table 3. Multivariate Logistic Regressions
Modeling UAVI
AOR (95% CI)
Disclosure 0.09** (0.02, 0.43)
MSM 0.11* (0.17, 0.82)
MSW 0.091 (0.01, 1.45)
Disclosure x MSM 3.03 (0.36, 25.59)
Disclosure x MSW 5.63 (0.30, 12.26)
Age 0.94** (0.90, 0.98)
Time since diagnosis 0.99 (0.94, 1.06)
Partner HIV serostatusa 0.21** (0.09, 0.44)
UAVI, unprotected anal or vaginal sex. aReference group =
seroconcordant partner. Final n for full sample in multivariate
model = 230 (66 MSM, 66 MSW, 98 WSM); 1p < 0.10, *p < 0.05,
**p < 0.01.
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of methodological limitations. Data on serostatus disclosure
and unprotected sex, based as they often are on participant
self-report without substantiation from partners, may be
subject to recall and social desirability biases. We stressed
participant confidentiality and used an ACASI to help mini-
mize these biases56,57 but it is still possible that people over-
reported disclosure and under-reported unprotected sexual
activity. The question used to operationalize serostatus dis-
closure was purposely designed to be double-barreled, which
participants could have misinterpreted. However, because we
wanted to assess voluntary disclosure as opposed to inad-
vertent or ambiguous disclosure, such as accidentally leaving
an HIV medication pill bottle in clear view, we believe this
operationalization was appropriate for our purposes. In ad-
dition, we were not able to assess the timing of serostatus
disclosure relative to sexual activity, since our data were
collected at the partner, not at the sexual episode level. Future
research could employ event-level analysis to more precisely
measure serostatus disclosure relative to the timing of sexual
activity. Length of sexual partnership was also not assessed
for those participants reporting a primary partner. This may
have been an unmeasured confounding factor in our analyses.
The current sample, particularly MSM and MSW, was rela-
tively small and it is possible that larger samples of these two
separate groups of men would have contributed greater sta-
tistical power to detect statistically significant differences not
observed in the current study. Finally, while our findings are
applicable to PLHIV receiving HIV-related medical care,
they may not be generalizable to individuals who are not in
clinical care, who are unaware of their serostatus, or who
report multiple sexual partners.
Conclusion
Our study contributes to the growing literature on unpro-
tected sex among HIV-positive adults by considering the role
of one aspect of sexual communication, specifically serostatus
disclosure, among a diverse clinically representative sample
of three distinct groups. The results are highly relevant to our
understanding of the sexual risk behaviors occurring within the
context of HIV-positive individuals’ sexual partnerships. First,
our results importantly suggest that most PLHIV who report
one sexual partner disclosed to that individual. Second, dis-
closure is inversely associated with unprotected sex. Future
strategies that aim to increase serostatus disclosure to sexual
partners may consider focusing on its value as a means by
which to reduce sexual risk behavior. Our findings support that
to prevent forward transmission, we target not only serostatus
disclosure among our interventions for PLHIV but also ac-
knowledge the importance of safer sex behavior messages.
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